Financial statements Biosense Technologies

Balance sheet of Biosense Technologies

Company age:
Age:
7 y. 11 m. 11 d.
Share capital:
Share capital:
8 000 PLN
Profit and loss statement Balance Profitability

Balance sheet data of BIOSENSE TECHNOLOGIES

Year
2017
2019
Total assets 160 735,40 186 556,70
A. Fixed assets 0,00 0,00
B. Current assets 160 735,40 186 556,70
C. Share capital contributions (basic funds) 0,00 0,00
D. Own shares (stocks) 0,00 0,00
Total liabilities 160 735,40 186 556,70
A. Equity 160 735,40 23 338,69
B. Liabilities and provisions for liabilities 13 646,92 163 218,01
I. Long-term liabilities 0,00 0,00
II. Short-term liabilities 13 646,92 163 218,01
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
  • Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
  • Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
  • Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
  • Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
  • Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
  • Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.